Plasma asymmetric dimethylarginine level and extent of lesion at coronary angiography

Sahinarslan A., Cengel A., Biberoglu G., Hasanoglu A., Turkoglu S., Timurkaynak T.

CORONARY ARTERY DISEASE, cilt.17, sa.7, ss.605-609, 2006 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Background Given that the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, can decrease nitric oxide bioavailability and lead to atherosclerosis, its concentration can be a good predictor for coronary artery disease. In this study, we investigated the relationship of plasma asymmetric dimethylarginine concentration with lesion distribution and severity at coronary artery angiography.